Medicine Description zanoglide 30/4 mg
Zanoglide 30/4 mg Tablets is a medication that combines glimepiride and pioglitazone, which work synergistically to enhance glycemic control in patients with type 2 diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin in response to elevated blood glucose levels. It also improves insulin sensitivity in peripheral tissues, facilitating glucose uptake. On the other hand, pioglitazone belongs to the thiazolidinedione class and primarily works by activating peroxisome proliferator-activated receptor gamma (PPAR-γ), resulting in increased insulin sensitivity in muscle and adipose tissues. This dual action helps to lower blood sugar levels more effectively by addressing both insulin secretion and insulin action.
Indications and Uses of Zanoglide 30/4 mg Tablets
- Management of blood sugar levels in adults with type 2 diabetes mellitus.
- Improvement of insulin sensitivity and reduction of insulin resistance.
- Part of a broader diabetes management plan that includes diet and exercise.
Side Effects of Zanoglide 30/4 mg Tablets
- Hypoglycemia (low blood sugar levels)
- Weight gain
- Edema (swelling due to fluid retention)
- Gastrointestinal disturbances (nausea, diarrhea)
- Increased risk of heart failure
- Liver enzyme elevations
Storage and Handling
Store Zanoglide tablets at room temperature, away from moisture and heat. Keep the medication in a secure place, inaccessible to children.
Patient Advice and Precautions
Regularly monitor blood glucose levels to assess the effectiveness of treatment.Maintain a balanced diet and engage in regular physical activity for optimal results.Consult your healthcare provider about any unusual symptoms or side effects.Inform your doctor about any other medications you are taking to avoid potential drug interactions.Attend regular follow-up appointments to evaluate your treatment plan and make necessary adjustments.